Press Releases Press Releases Year None20192018201720162015 February 4, 2019 Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388 Read More January 16, 2019 Publication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint Proteins Read More January 4, 2019 Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board Read More Print Page RSS Email Alerts Contact IR Search
Press Releases Year None20192018201720162015 February 4, 2019 Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388 Read More January 16, 2019 Publication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint Proteins Read More January 4, 2019 Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board Read More
February 4, 2019 Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388 Read More
January 16, 2019 Publication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint Proteins Read More
January 4, 2019 Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board Read More
